Dernière mise à jour: Août 17, 2026

Nouvelle perspective sur la production de cellules sanguines et de cellules immunitaires

 

A healthy adult makes about 2 millions de cellules sanguines chaque seconde, et 99 pour cent d’entre eux sont des globules rouges qui transportent l’oxygène. Le 1% restant est constitué de plaquettes et de divers globules blancs du système immunitaire.. How all the different kinds of mature blood cells are derived from the same “hématopoïétique” stem cells in the bone marrow has been the subject of intense research, but most studies have focused on the one percent, the immune cells.

 

Their findings are important for understanding disorders such as anemia, diseases of the immune system, and blood cancers such as leukemias and lymphomas.

 

The process by which hematopoietic stem cells give rise to mature blood cells involves multiple populations of progenitor cells that become progressively more committed to a specificfateas they develop into fully mature cells. A major fork in the road is betweenlymphoid progenitors,” which give rise to white blood cells called lymphocytes, et “myeloid progenitors,” which give rise to other kinds of white blood cells, as well as red blood cells and platelets. The majority of cells in the bone marrow are in the myeloid lineage.

A key finding of the new study is that all progenitor cells with myeloid potential produce far more red blood cells than any other cell type. This was surprising because many previous studies in which progenitor cells were grown in cell cultures (“in vitro”) found they had limited capacity to produce red blood cells and platelets. Forsberg said those results now appear to be an artifact of the culture conditions.

It’s been hard to make sense of a lot of those experiments, because we know our bodies need to make a lot of red blood cells and platelets,” elle a dit. “Our results show that these progenitor cells retain a lot of red blood cell potential. En fait, we propose that red blood cell production is the default pathway.

 

By quantifying the numbers of mature blood cells produced from transplanted progenitors, the researchers were able to show that red blood cells were by far the most abundant cell type produced by every type of progenitor cell, with the exception of lymphoid progenitors. Their findings led to the development of a model of hematopoietic differentiation that focuses on red blood cells as the default pathway for all myeloid progenitors.

 

Revue de cas scientifique

Examen de cas scientifiques

Souhaitez-vous savoir si les programmes cliniques actuels, développements récents en recherche, ou des approches émergentes peuvent être adapté à votre situation individuelle?

Partagez votre question avec notre équipe de recherche scientifique et recevez informations axées sur les domaines de recherche en cours qui peuvent être pertinent pour votre cas.

  • Examen des informations que vous fournissez
  • Informations pertinentes sur la recherche et les programmes cliniques
  • Une réponse claire et adaptée à votre situation
Que se passe-t-il ensuite? Envoyez votre question, recevoir une évaluation scientifique ciblée, et obtenez une réponse claire sur les programmes de recherche et cliniques pertinents à votre situation.
Votre revue scientifique sera préparée par Docteur. Hélène Melnik, Doctorat , qui a plus de 25 années d'expérience dans la recherche sur les cellules souches et les programmes cliniques internationaux.

Aucune obligation. Votre question sera examinée de manière confidentielle.

Informations pédagogiques et de recherche uniquement. Ce service ne constituer un avis médical, diagnostic, ordonnance, ou un personnalisé recommandation de traitement.


NBScience

organisme de recherche sous contrat

WhatsApp